kanamycin a has been researched along with oridonin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Ke, Z; Li, M; Li, Y; Liu, K; Qiao, Y; Shi, X; Wang, Y; Wu, L; Zheng, L | 1 |
1 other study(ies) available for kanamycin a and oridonin
| Article | Year |
|---|---|
Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3/caspase-1/gasdermin D-induced inflammasome activation and hair cell pyroptosis.
Topics: Animals; Caspase 1; Diterpenes, Kaurane; Hair; Hearing Loss; Inflammasomes; Interleukin-1beta; Kanamycin; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Reactive Oxygen Species | 2022 |